A61K 31/4439
Containing a five-membered ring with nitrogen as a ring hetero atom
Official title: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465)
A61K31/4439 (Containing a five-membered ring with nitrogen as a ring hetero atom) appears on 4,928 US grants and 9,191 published applications in this corpus.
Search patents in A61K- Granted patents
- 4,928
- Published applications
- 9,191
- Assignees
- 2,747
- Inventors
- 18,681
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 7 | 0 |
| 1996 | 6 | 0 |
| 1997 | 26 | 0 |
| 1998 | 43 | 0 |
| 1999 | 51 | 0 |
| 2000 | 72 | 0 |
| 2001 | 112 | 34 |
| 2002 | 81 | 122 |
| 2003 | 72 | 175 |
| 2004 | 63 | 224 |
| 2005 | 55 | 209 |
| 2006 | 58 | 190 |
| 2007 | 53 | 175 |
| 2008 | 64 | 178 |
| 2009 | 51 | 207 |
| 2010 | 83 | 261 |
| 2011 | 100 | 269 |
| 2012 | 127 | 275 |
| 2013 | 197 | 405 |
| 2014 | 253 | 488 |
| 2015 | 343 | 510 |
| 2016 | 309 | 520 |
| 2017 | 376 | 493 |
| 2018 | 327 | 470 |
| 2019 | 352 | 499 |
| 2020 | 325 | 478 |
| 2021 | 271 | 467 |
| 2022 | 231 | 490 |
| 2023 | 196 | 468 |
| 2024 | 242 | 529 |
| 2025 | 206 | 571 |
| 2026 | 170 | 484 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- PHD inhibitor compounds, compositions, and use6 Oct 2026US 12,753,161 B2Akebia Therapeutics, Inc.
- CCR6 receptor modulators6 Oct 2026US 12,753,168 B2Idorsia Pharmaceuticals Ltd
- Amorphous substances, crystals, pharmaceutical compositions, preparation methods and uses of thiohydantoin compound or pharmaceutically acceptable salt thereof6 Oct 2026US 12,753,173 B2Suzhou Kintor Pharmaceuticals, Inc.
- Liquid, storage stable, directly injectable, pantoprazole formulations, their uses and manufacturing29 Sep 2026US 12,746,199 B2Etico Lifesciences Private Limited
- Anticancer compositions29 Sep 2026US 12,746,230 B2Aragon Pharmaceuticals, Inc.
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Polymorphic forms and formulations of leriglitazone8 Oct 2026US 2026/0306468 A1Minoryx Therapeutics S.L.
- Ocular implant containing a tyrosine kinase inhibitor8 Oct 2026US 2026/0306469 A1Ocular Therapeutix, Inc.
- Anti-inflammatory compounds, pharmaceutical compositions, and methods of treating hemochromatosis and other disorders8 Oct 2026US 2026/0306470 A1Miralogx LLC
- Tomm6-interacting extracts and compounds for use in the treatment and prophylaxis of nervous system diseases, atherosclerosis, hepatitis b infection and human papilloma virus (hpv) infection8 Oct 2026US 2026/0306473 A1
Most cited
By later US patents
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015
- Liquid delivery compositions268US 5,780,044 AAtrix Laboratories, Inc. · 1998
- Liquid delivery compositions243US 5,744,153 AAtrix Laboratories, Inc. · 1998
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006
- Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof170US 7,074,801 B1Eisai Co., Ltd. · 2006